Abeona Therapeutics' (ABEO) "Buy" Rating Reaffirmed at HC Wainwright

Abeona Therapeutics' (ABEO)

Private Advisor Group LLC now owns 21,005 shares of the biopharmaceutical company's stock valued at $108,000 after purchasing an additional 6,999 shares during the period. The firm has "Underperform" rating by Evercore given on Friday, June 30. The rating was maintained by Panmure Gordon with "Buy" on Wednesday, March 15. The rating has been released in a research note on Monday, 18 September. In the past 6 weeks our success rate is 90%. As per Tuesday, October 27, the company rating was maintained by Oppenheimer.

The market capitalization (Stock Price Multiply by Total Number of Outstanding Shares) for the company is reported at $563.99M. During last 3 month period, 9.92% of total institutional ownership has changed in the company shares. The mean target price stands at $19.40. The stock exchanged hands with 4,322,770 numbers of shares compared to its average daily volume of 810.63K shares. (NASDAQ:ABEO) expressed a change of 22.86% and closed its trade at $17.20. Its up 0.50, from 2 in 2016Q3. Its up 0.24, from 0.64 in 2016Q3. It fall, as 67 investors sold RAD shares while 114 reduced holdings. 5 funds opened positions while 5 raised stakes. Unusual volume can be a major signal that investment gurus and momentum traders are piling into a stock ahead of a catalyst. Pitcairn Company holds 40,463 shares. (NASDAQ:ABEO) Performing Well? Kcg stated it has 11,977 shares. Argent Capital Mngmt Limited Liability Company has invested 0.01% in Rite Aid Corporation (NYSE:RAD). California Pub Employees Retirement Systems accumulated 86,700 shares or 0% of the stock. Finally, Essex Investment Management Co.

Merrimack Pharmaceuticals, a biopharmaceutical company. Shares are now up +246.08% over the past year, outperforming the broad market by 1462.41% and outperformed a peer group of similar companies by 5627%. The Firm is engaged in discovering, developing and commercializing medicines consisting of therapeutics paired with companion diagnostics for the treatment of cancer. About 187,435 shares traded. Ekf Diagnostics Holding PLC (LON:EKF) has 0.00% since September 15, 2016 and is. It has underperformed by 71.88% the S&P500.

Abeona Therapeutics a clinical-stage biopharmaceutical firm developing novel gene therapies for life-threatening rare genetic diseases. The mean target price as estimated by the analysts for the company has been recorded at $20.00. The Company's lead programs include ABO-102, an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB). 1 firm rating the stock a strong buy, 3 firms rating the stock a buy, 0 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 equity analysts rating the company a sell with a one year target of $12.38. Therefore 100% are positive. Abeona Therapeutics has a one year low of $4.05 and a one year high of $17.25.

In a report issued on September 14, RBC Capital also initiated coverage with a Buy rating on the stock with a $23 price target. Maxim Group maintained the stock with "Buy" rating in Thursday, September 29 report.

HC Wainwright restated their buy rating on shares of Abeona Therapeutics Inc. Maxim Group maintained it with "Buy" rating and $17.0 target in Wednesday, August 16 report. "(ABEO) Receives Buy Rating from HC Wainwright" was reported by Equities Focus and is owned by of Equities Focus. The stock of Abeona Therapeutics Inc (NASDAQ:ABEO) earned "Buy" rating by Rodman & Renshaw on Wednesday, April 20.

Abeona Therapeutics (NASDAQ:ABEO) last posted its quarterly earnings data on Tuesday, August 15th. The firm has "Buy" rating by Maxim Group given on Tuesday, August 29. In general, if the indicator goes above -20, the stock may be considered overbought.

Like this



20 September 2017
Bed Bath & Beyond misses Street 2Q forecasts
Perritt Capital Management Inc, a Illinois-based fund reported 72,450 shares. (NASDAQ:BBBY) for 74,191 shares. Gfs Advisors Llc decreased Ishares Tr (IGE) stake by 10,889 shares to 22,042 valued at $792,000 in 2016Q4.

20 September 2017
Fiat Chrysler Recalls Ram Trucks Over Water Pump Issue
Fiat Chrysler said Tuesday it is recalling 494,000 Ram pickup trucks, model years 2013-2017, saying they pose a fire risk. Most of the 494,417 vehicles involved were sold in the USA , and another 46,220 are in Canada.

20 September 2017
Timmons suspended indefinitely by Dolphins after going AWOL
He spent his first 10 National Football League seasons with the Pittsburgh Steelers , recording 677 tackles and 35.5 sacks. The good news is that Timmons is okay, and whatever business that he has with his family is his and his alone.

20 September 2017
Billy Bush And His Wife Of 20 Years Have Split
The ousted TV host and his wife Sydney Davis have been married for 20 years and have three daughters together. Bush's representative also confirmed the split to the publication and denied rumors that Davis left him.

20 September 2017
Revenue Estimates Analysis Of Cenovus Energy Inc. (CVE)
Technical analysis is as a method that applies to take a guess of future price trends through analyzing market action. The fund owned 5,648,277 shares of the oil and gas company's stock after selling 1,306,271 shares during the quarter.

20 September 2017
NextEra Energy's (NYSE:NEE) "Buy" Rating Reiterated at KeyCorp
Therefore 92% are positive. 4,458 NextEra Energy Inc (NYSE:NEE) shares with value of $584,971 were sold by Arechabala Miguel. Bluefin Trading Limited Liability Company stated it has 2,697 shares. 2,879 are owned by Northwestern Mutual Wealth Mgmt.

20 September 2017
US Current Account Deficit Hits $123.1 Billion in Q2
Imports of goods and services and income payments increased $11.8 billion to $959.9 billion. The U.S. has run persistent trade deficits for decades by importing more than it exports.

20 September 2017
Adobe Systems Incorporated (ADBE) is WestEnd Advisors LLC's 5th Largest Position
Adobe noted that Digital Media segment revenue was $1.27 billion in the latest period, while Creative revenue was $1.06 billion. The stock has performed -0.70% over the last seven days, 5.09% over the last thirty, and 10.99% over the last three months.

20 September 2017
Goldman Sachs Group, Inc. (The) Reaffirms "Sell" Rating for AstraZeneca plc (AZN)
The shares were purchased at an average cost of GBX 4,370 ($58.92) per share, for a total transaction of £1,704.30 ($2,297.83). Several analysts have released their opinion on AstraZeneca PLC (NYSE: AZN ), with 2 analysts believing it is a strong buy.

19 September 2017
Google Pixelbook is Google's New Chromebook With Pixelbook Pen, Starting at $1199
The upcoming Chromebook will come in a silver color option and buyers will be able to choose from 128GB, 256GB, or 512GB variants. The company is set to have a big hardware event on the 4th of October, but nearly all of the announcements have leaked already.